Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Earnings
Alexandria Real Estate raises construction spending view to $1.35B from $960M » 16:21
07/27/20
07/27
16:21
07/27/20
16:21
ARE

Alexandria Real Estate

$170.23 /

+1.645 (+0.98%)

Our guidance issued on…

Our guidance issued on July 27 was updated to address the continuing tenant demand for our development and redevelopment pipeline in part due to COVID-19 requirements, as well as existing and anticipated attractive acquisition opportunities in our markets, which will be partially funded through forecasted real estate dispositions and partial interest sales. Key updates to our sources and uses include: Increased midpoint for our 2020 construction spending guidance range from $960 to $1.35B; an additional $900M to $1.3B of real estate acquisitions in 2H20, including acquisitions completed in July; increased midpoint of our real estate dispositions and partial interest sales from $50.0M-$1.25B, which is expected to fund a portion of the increase in construction spending and acquisitions in addition to providing significant capital for growth over the next two to three quarters.

ShowHide Related Items >><<
ARE Alexandria Real Estate
$170.23 /

+1.645 (+0.98%)

ARE Alexandria Real Estate
$170.23 /

+1.645 (+0.98%)

07/20/20 Mizuho
Alexandria Real Estate price target lowered to $185 from $190 at Mizuho
06/08/20 JMP Securities
Alexandria Real Estate resumed with an Outperform at JMP Securities
02/04/20 Mizuho
Alexandria Real Estate assumed with a Buy at Mizuho
12/18/19 JPMorgan
JPMorgan makes 17 REIT rating changes in conjunction with 2020 outlook
ARE Alexandria Real Estate
$170.23 /

+1.645 (+0.98%)

  • 07
    Jul
  • 07
    Jan
ARE Alexandria Real Estate
$170.23 /

+1.645 (+0.98%)

ARE Alexandria Real Estate
$170.23 /

+1.645 (+0.98%)

Earnings
Alexandria Real Estate reports Q2 FFO $1.81, consensus $1.81 » 16:19
07/27/20
07/27
16:19
07/27/20
16:19
ARE

Alexandria Real Estate

$170.23 /

+1.645 (+0.98%)

Reports Q2 revenue…

Reports Q2 revenue $437.0M, consensus $339.45M. Reports Q2 NOI of $1.1B annualized, up $165.0M, or 17.6%, compared to 2Q19 annualized.

ShowHide Related Items >><<
ARE Alexandria Real Estate
$170.23 /

+1.645 (+0.98%)

ARE Alexandria Real Estate
$170.23 /

+1.645 (+0.98%)

07/20/20 Mizuho
Alexandria Real Estate price target lowered to $185 from $190 at Mizuho
06/08/20 JMP Securities
Alexandria Real Estate resumed with an Outperform at JMP Securities
02/04/20 Mizuho
Alexandria Real Estate assumed with a Buy at Mizuho
12/18/19 JPMorgan
JPMorgan makes 17 REIT rating changes in conjunction with 2020 outlook
ARE Alexandria Real Estate
$170.23 /

+1.645 (+0.98%)

  • 07
    Jul
  • 07
    Jan
ARE Alexandria Real Estate
$170.23 /

+1.645 (+0.98%)

ARE Alexandria Real Estate
$170.23 /

+1.645 (+0.98%)

Recommendations
Alexandria Real Estate price target lowered to $185 from $190 at Mizuho » 07:04
07/20/20
07/20
07:04
07/20/20
07:04
ARE

Alexandria Real Estate

$166.75 /

+3.65 (+2.24%)

Mizuho analyst Omotayo…

Mizuho analyst Omotayo Okusanya lowered the firm's price target on Alexandria Real Estate to $185 from $190 and keeps a Buy rating on the shares. The analyst reduced earnings estimates across the office real estate investment trust sector to reflect the view that resolution of the COVID-19 pandemic is increasingly looking like a 2021, not 2020, event. This suggests employees work from home longer, creating a "more permanent change" in employee behavior which has negative ramification for office fundamentals, Okusanya tells investors in a research note.

ShowHide Related Items >><<
ARE Alexandria Real Estate
$166.75 /

+3.65 (+2.24%)

ARE Alexandria Real Estate
$166.75 /

+3.65 (+2.24%)

06/08/20 JMP Securities
Alexandria Real Estate resumed with an Outperform at JMP Securities
02/04/20 Mizuho
Alexandria Real Estate assumed with a Buy at Mizuho
12/18/19 JPMorgan
JPMorgan makes 17 REIT rating changes in conjunction with 2020 outlook
12/18/19 RBC Capital
Alexandria Real Estate downgraded to Outperform from Top Pick at RBC Capital
ARE Alexandria Real Estate
$166.75 /

+3.65 (+2.24%)

  • 07
    Jul
  • 07
    Jan
ARE Alexandria Real Estate
$166.75 /

+3.65 (+2.24%)

ARE Alexandria Real Estate
$166.75 /

+3.65 (+2.24%)

On The Fly
Fly Intel: Pre-market Movers » 09:11
07/07/20
07/07
09:11
07/07/20
09:11
NVAX

Novavax

$79.35 /

-2.3 (-2.82%)

, CRVS

Corvus Pharmaceuticals

$2.76 /

+0.21 (+8.24%)

, LVGO

Livongo Health

$77.57 /

+4.77 (+6.55%)

, RUN

Sunrun

$21.35 /

+1.35 (+6.75%)

, VSLR

Vivint Solar

$10.63 /

+0.555 (+5.51%)

, ENDP

Endo

$3.62 /

+0.12 (+3.43%)

, REGN

Regeneron

$626.65 /

+5.89 (+0.95%)

, EOLS

Evolus

$5.33 /

-0.15 (-2.74%)

, D

Dominion

$73.60 /

-9.085 (-10.99%)

, ARE

Alexandria Real Estate

$164.78 /

-0.08 (-0.05%)

, COMM

CommScope

$8.68 /

+0.28 (+3.33%)

Check out this morning's…

Open Full Text

ShowHide Related Items >><<
VSLR Vivint Solar
$10.63 /

+0.555 (+5.51%)

RUN Sunrun
$21.35 /

+1.35 (+6.75%)

REGN Regeneron
$626.65 /

+5.89 (+0.95%)

NVAX Novavax
$79.35 /

-2.3 (-2.82%)

LVGO Livongo Health
$77.57 /

+4.77 (+6.55%)

EOLS Evolus
$5.33 /

-0.15 (-2.74%)

ENDP Endo
$3.62 /

+0.12 (+3.43%)

D Dominion
$73.60 /

-9.085 (-10.99%)

CRVS Corvus Pharmaceuticals
$2.76 /

+0.21 (+8.24%)

COMM CommScope
$8.68 /

+0.28 (+3.33%)

ARE Alexandria Real Estate
$164.78 /

-0.08 (-0.05%)

NVAX Novavax
$79.35 /

-2.3 (-2.82%)

07/02/20 B. Riley FBR
Novavax should be bought on weakness from Pfizer data, says B. Riley FBR
06/29/20 B. Riley FBR
Novavax price target raised to $106 from $74 at B. Riley FBR
06/29/20 H.C. Wainwright
Novavax price target raised to $101 from $50 at H.C. Wainwright
06/19/20 Cantor Fitzgerald
Novavax price target raised to $88 from $45 at Cantor Fitzgerald
CRVS Corvus Pharmaceuticals
$2.76 /

+0.21 (+8.24%)

03/10/20 H.C. Wainwright
Corvus Pharmaceuticals initiated with a Buy at H.C. Wainwright
12/09/19 Mizuho
Corvus pipeline updates 'can only be additive,' says Mizuho
09/12/19 Mizuho
Mizuho starts Corvus Pharmaceuticals with Buy rating, $7 price target
09/11/19 Mizuho
Corvus Pharmaceuticals initiated with a Buy at Mizuho
LVGO Livongo Health
$77.57 /

+4.77 (+6.55%)

07/07/20 KeyBanc
Livongo Health experiencing higher member enrollment, retention, says KeyBanc
07/06/20 Stephens
Livongo initiated with Overweight, named Best Idea at Stephens
07/02/20
Fly Intel: Top five analyst downgrades
07/02/20 Goldman Sachs
Livongo Health downgraded to Neutral from Buy at Goldman Sachs
RUN Sunrun
$21.35 /

+1.35 (+6.75%)

07/07/20 JMP Securities
Vivint Solar downgraded to Market Perform from Outperform at JMP Securities
07/06/20 JMP Securities
Sunrun price target raised to $31 from $19 at JMP Securities
06/15/20 Credit Suisse
Sunrun price target raised to $29 from $18 at Credit Suisse
06/02/20 Roth Capital
Roth says loan securitizations reopening a positive for residential solar names
VSLR Vivint Solar
$10.63 /

+0.555 (+5.51%)

06/24/20 Goldman Sachs
Vivint Solar downgraded to Neutral from Buy at Goldman Sachs
06/05/20 JMP Securities
Vivint Solar price target raised to $15 from $10 at JMP Securities
ENDP Endo
$3.62 /

+0.12 (+3.43%)

06/17/20 Citi
Sell Mallinckrodt, buy Endo with opioid risk coming back, says Citi
04/24/20
Fly Intel: Top five analyst initiations
04/24/20 Citi
Endo initiated with a Buy at Citi
01/03/20 Piper Sandler
Endo upgraded to Overweight from Neutral at Piper Jaffray
REGN Regeneron
$626.65 /

+5.89 (+0.95%)

07/01/20 Oppenheimer
Regeneron price target raised to $675 from $625 at Oppenheimer
06/24/20 Credit Suisse
Regeneron price target raised to $700 from $605 at Credit Suisse
06/24/20 Morgan Stanley
Novartis' syringe suit not a material threat to Regeneron, says Morgan Stanley
06/18/20 Piper Sandler
AbbVie atopic dermatitis data a postive, says Piper Sandler
EOLS Evolus
$5.33 /

-0.15 (-2.74%)

07/07/20 Truist
Evolus price target lowered to $6 from $12 at SunTrust
07/07/20 Mizuho
Evolus downgraded to Neutral from Buy at Mizuho
07/07/20 H.C. Wainwright
Evolus price target lowered to $7 from $15 at H.C. Wainwright
06/02/20 Mizuho
Evolus fundamentals unchanged despite ITC delay, says Mizuho
D Dominion
$73.60 /

-9.085 (-10.99%)

07/07/20 Argus
Dominion price target lowered to $80 from $87 at Argus
07/07/20 Mizuho
Dominion downgraded to Underperform from Neutral at Mizuho
07/07/20 Credit Suisse
Dominion downgraded to Neutral from Outperform at Credit Suisse
07/06/20 Wells Fargo
Wells says merits of Dominion's 'forward-looking' deal to be clearer with time
ARE Alexandria Real Estate
$164.78 /

-0.08 (-0.05%)

06/08/20 JMP Securities
Alexandria Real Estate resumed with an Outperform at JMP Securities
02/04/20 Mizuho
Alexandria Real Estate assumed with a Buy at Mizuho
12/18/19 JPMorgan
JPMorgan makes 17 REIT rating changes in conjunction with 2020 outlook
12/18/19 RBC Capital
Alexandria Real Estate downgraded to Outperform from Top Pick at RBC Capital
COMM CommScope
$8.68 /

+0.28 (+3.33%)

07/07/20 Raymond James
CommScope downgraded to Market Perform at Raymond James on valuation
07/07/20 Raymond James
CommScope downgraded to Market Perform from Outperform at Raymond James
07/06/20 Rosenblatt
Samsung on track to replace Nokia as 5G RAN supplier at Verizon, says Rosenblatt
06/25/20 Raymond James
CommScope price target lowered to $10 from $12 at Raymond James
VSLR Vivint Solar
$10.63 /

+0.555 (+5.51%)

RUN Sunrun
$21.35 /

+1.35 (+6.75%)

REGN Regeneron
$626.65 /

+5.89 (+0.95%)

NVAX Novavax
$79.35 /

-2.3 (-2.82%)

LVGO Livongo Health
$77.57 /

+4.77 (+6.55%)

EOLS Evolus
$5.33 /

-0.15 (-2.74%)

ENDP Endo
$3.62 /

+0.12 (+3.43%)

D Dominion
$73.60 /

-9.085 (-10.99%)

CRVS Corvus Pharmaceuticals
$2.76 /

+0.21 (+8.24%)

COMM CommScope
$8.68 /

+0.28 (+3.33%)

ARE Alexandria Real Estate
$164.78 /

-0.08 (-0.05%)

  • 07
    Jul
  • 27
    May
  • 07
    Jan
  • 12
    Dec
  • 07
    Nov
  • 25
    Jul
VSLR Vivint Solar
$10.63 /

+0.555 (+5.51%)

REGN Regeneron
$626.65 /

+5.89 (+0.95%)

NVAX Novavax
$79.35 /

-2.3 (-2.82%)

LVGO Livongo Health
$77.57 /

+4.77 (+6.55%)

ENDP Endo
$3.62 /

+0.12 (+3.43%)

D Dominion
$73.60 /

-9.085 (-10.99%)

ARE Alexandria Real Estate
$164.78 /

-0.08 (-0.05%)

VSLR Vivint Solar
$10.63 /

+0.555 (+5.51%)

RUN Sunrun
$21.35 /

+1.35 (+6.75%)

REGN Regeneron
$626.65 /

+5.89 (+0.95%)

NVAX Novavax
$79.35 /

-2.3 (-2.82%)

LVGO Livongo Health
$77.57 /

+4.77 (+6.55%)

ENDP Endo
$3.62 /

+0.12 (+3.43%)

D Dominion
$73.60 /

-9.085 (-10.99%)

COMM CommScope
$8.68 /

+0.28 (+3.33%)

ARE Alexandria Real Estate
$164.78 /

-0.08 (-0.05%)

VSLR Vivint Solar
$10.63 /

+0.555 (+5.51%)

RUN Sunrun
$21.35 /

+1.35 (+6.75%)

REGN Regeneron
$626.65 /

+5.89 (+0.95%)

NVAX Novavax
$79.35 /

-2.3 (-2.82%)

LVGO Livongo Health
$77.57 /

+4.77 (+6.55%)

EOLS Evolus
$5.33 /

-0.15 (-2.74%)

ENDP Endo
$3.62 /

+0.12 (+3.43%)

D Dominion
$73.60 /

-9.085 (-10.99%)

COMM CommScope
$8.68 /

+0.28 (+3.33%)

Syndicate
Alexandria Real Estate 5M share Spot Secondary priced at $160.50 » 06:43
07/07/20
07/07
06:43
07/07/20
06:43
ARE

Alexandria Real Estate

$164.78 /

-0.08 (-0.05%)

The deal size was…

The deal size was increased to 6M shares of common stock from 5M shares of common stock and priced within the $158.20-$163.15 range. Citi, BofA, Goldman Sachs and JPMorgan acted as joint book running managers for the offering.

ShowHide Related Items >><<
ARE Alexandria Real Estate
$164.78 /

-0.08 (-0.05%)

ARE Alexandria Real Estate
$164.78 /

-0.08 (-0.05%)

06/08/20 JMP Securities
Alexandria Real Estate resumed with an Outperform at JMP Securities
02/04/20 Mizuho
Alexandria Real Estate assumed with a Buy at Mizuho
12/18/19 JPMorgan
JPMorgan makes 17 REIT rating changes in conjunction with 2020 outlook
12/18/19 RBC Capital
Alexandria Real Estate downgraded to Outperform from Top Pick at RBC Capital
ARE Alexandria Real Estate
$164.78 /

-0.08 (-0.05%)

  • 07
    Jul
  • 07
    Jan
ARE Alexandria Real Estate
$164.78 /

-0.08 (-0.05%)

ARE Alexandria Real Estate
$164.78 /

-0.08 (-0.05%)

On The Fly
Fly Intel: After-Hours Movers » 19:08
07/06/20
07/06
19:08
07/06/20
19:08
OTIC

Otonomy

$3.19 /

+0.02 (+0.63%)

, XSPA

XpresSpa

$3.79 /

-0.2 (-5.01%)

, CEMI

Chembio Diagnostics

$4.02 /

-0.15 (-3.60%)

, GLDD

Great Lakes Dredge

$8.85 /

+0.04 (+0.45%)

, PSN

Parsons

$34.56 /

-0.37 (-1.06%)

, KINS

Kingstone Companies

$4.41 /

-0.01 (-0.23%)

, MARK

Remark Holdings

$2.61 /

+0.235 (+9.89%)

, CLLS

Cellectis

$19.04 /

+0.42 (+2.26%)

, TRIB

Trinity Biotech

$2.54 /

+0.23 (+9.96%)

, RVMD

Revolution Medicines

$29.27 /

-1.73 (-5.58%)

, PCRX

Pacira

$54.13 /

+1.93 (+3.70%)

, ARE

Alexandria Real Estate

$164.78 /

-0.08 (-0.05%)

, KMI

Kinder Morgan

$15.20 /

+0.07 (+0.46%)

Check out this evening's…

Open Full Text

ShowHide Related Items >><<
XSPA XpresSpa
$3.79 /

-0.2 (-5.01%)

TRIB Trinity Biotech
$2.54 /

+0.23 (+9.96%)

RVMD Revolution Medicines
$29.27 /

-1.73 (-5.58%)

PSN Parsons
$34.56 /

-0.37 (-1.06%)

PCRX Pacira
$54.13 /

+1.93 (+3.70%)

OTIC Otonomy
$3.19 /

+0.02 (+0.63%)

MARK Remark Holdings
$2.61 /

+0.235 (+9.89%)

KMI Kinder Morgan
$15.20 /

+0.07 (+0.46%)

GLDD Great Lakes Dredge
$8.85 /

+0.04 (+0.45%)

CLLS Cellectis
$19.04 /

+0.42 (+2.26%)

CEMI Chembio Diagnostics
$4.02 /

-0.15 (-3.60%)

ARE Alexandria Real Estate
$164.78 /

-0.08 (-0.05%)

OTIC Otonomy
$3.19 /

+0.02 (+0.63%)

06/15/20 Piper Sandler
Piper remains optimistic on Otonomy ahead of near-term clinical readouts
06/01/20 Oppenheimer
Otonomy assumed with an Outperform at Oppenheimer
05/07/20 Piper Sandler
Piper still believes in potential success of three key Otonomy programs
02/07/20 Piper Sandler
Otonomy should be bought ahead of near-term readouts, says Piper Sandler
XSPA XpresSpa
$3.79 /

-0.2 (-5.01%)

CEMI Chembio Diagnostics
$4.02 /

-0.15 (-3.60%)

06/17/20
Fly Intel: Top five analyst downgrades
06/17/20 Craig-Hallum
Chembio Diagnostics downgraded to Hold from Buy at Craig-Hallum
06/17/20 Colliers
Chembio Diagnostics downgraded to Neutral from Buy at Colliers
06/17/20 Canaccord
Chembio Diagnostics downgraded to Hold at Canaccord
GLDD Great Lakes Dredge
$8.85 /

+0.04 (+0.45%)

PSN Parsons
$34.56 /

-0.37 (-1.06%)

05/05/20 Wells Fargo
Parsons price target raised to $39 from $33 at Wells Fargo
04/15/20 Benchmark
Parsons initiated with a Buy at Benchmark
04/02/20 Wells Fargo
Parsons price target lowered to $33 from $42 at Wells Fargo
03/30/20 William Blair
Parsons initiated with an Outperform at William Blair
KINS Kingstone Companies
$4.41 /

-0.01 (-0.23%)

MARK Remark Holdings
$2.61 /

+0.235 (+9.89%)

06/10/20 Roth Capital
Roth checks point to Kent Services as Remark Holdings distribution partner
05/27/20 Roth Capital
Wynn video 'clearly shows' Remark AI technology in use, says Roth Capital
07/15/19 Roth Capital
Sharecare liquidity event would help capitalize Remark AI business, says Roth Capital
CLLS Cellectis
$19.04 /

+0.42 (+2.26%)

05/12/20
Fly Intel: Top five analyst initiations
05/11/20 Baird
Cellectis initiated with an Outperform at Baird
03/06/20 Citi
Cellectis price target raised to $16 from $14 at Citi
03/06/20 Goldman Sachs
Cellectis downgraded to Sell from Neutral at Goldman Sachs
TRIB Trinity Biotech
$2.54 /

+0.23 (+9.96%)

RVMD Revolution Medicines
$29.27 /

-1.73 (-5.58%)

05/21/20
Fly Intel: Top five analyst initiations
05/21/20 H.C. Wainwright
Revolution Medicines initiated with a Buy at H.C. Wainwright
03/09/20
Fly Intel: Top five analyst initiations
03/09/20 Cowen
Revolution Medicines initiated with an Outperform at Cowen
PCRX Pacira
$54.13 /

+1.93 (+3.70%)

07/06/20 Needham
Pacira price target raised to $64 from $52 at Needham
07/06/20 Piper Sandler
Pacira price target raised to $65 from $49 at Piper Sandler
07/01/20 RBC Capital
Pacira price target raised to $62 from $56 at RBC Capital
06/30/20 SVB Leerink
Pacira price target raised to $58 from $45 at SVB Leerink
ARE Alexandria Real Estate
$164.78 /

-0.08 (-0.05%)

06/08/20 JMP Securities
Alexandria Real Estate resumed with an Outperform at JMP Securities
02/04/20 Mizuho
Alexandria Real Estate assumed with a Buy at Mizuho
12/18/19 JPMorgan
JPMorgan makes 17 REIT rating changes in conjunction with 2020 outlook
12/18/19 RBC Capital
Alexandria Real Estate downgraded to Outperform from Top Pick at RBC Capital
KMI Kinder Morgan
$15.20 /

+0.07 (+0.46%)

07/06/20 Goldman Sachs
Kinder Morgan downgraded to Sell from Neutral at Goldman Sachs
05/18/20 BofA
Plains All American, GP Holdings cut to Underperform at BofA
04/07/20 Mizuho
Kinder Morgan price target lowered to $20 from $23 at Mizuho
03/24/20 Barclays
Kinder Morgan upgraded to Overweight from Equal Weight at Barclays
TRIB Trinity Biotech
$2.54 /

+0.23 (+9.96%)

PSN Parsons
$34.56 /

-0.37 (-1.06%)

PCRX Pacira
$54.13 /

+1.93 (+3.70%)

OTIC Otonomy
$3.19 /

+0.02 (+0.63%)

MARK Remark Holdings
$2.61 /

+0.235 (+9.89%)

KMI Kinder Morgan
$15.20 /

+0.07 (+0.46%)

KINS Kingstone Companies
$4.41 /

-0.01 (-0.23%)

GLDD Great Lakes Dredge
$8.85 /

+0.04 (+0.45%)

CLLS Cellectis
$19.04 /

+0.42 (+2.26%)

CEMI Chembio Diagnostics
$4.02 /

-0.15 (-3.60%)

ARE Alexandria Real Estate
$164.78 /

-0.08 (-0.05%)

  • 07
    Jul
  • 09
    Jul
  • 07
    May
  • 13
    Feb
  • 07
    Jan
KMI Kinder Morgan
$15.20 /

+0.07 (+0.46%)

ARE Alexandria Real Estate
$164.78 /

-0.08 (-0.05%)

RVMD Revolution Medicines
$29.27 /

-1.73 (-5.58%)

PSN Parsons
$34.56 /

-0.37 (-1.06%)

PCRX Pacira
$54.13 /

+1.93 (+3.70%)

MARK Remark Holdings
$2.61 /

+0.235 (+9.89%)

KMI Kinder Morgan
$15.20 /

+0.07 (+0.46%)

CEMI Chembio Diagnostics
$4.02 /

-0.15 (-3.60%)

XSPA XpresSpa
$3.79 /

-0.2 (-5.01%)

MARK Remark Holdings
$2.61 /

+0.235 (+9.89%)

KMI Kinder Morgan
$15.20 /

+0.07 (+0.46%)

CEMI Chembio Diagnostics
$4.02 /

-0.15 (-3.60%)

Syndicate
Alexandria Real Estate 5M share Spot Secondary; price range $158.20-$163.15 » 16:15
07/06/20
07/06
16:15
07/06/20
16:15
ARE

Alexandria Real Estate

$164.78 /

-0.08 (-0.05%)

Citi is acting as lead…

Citi is acting as lead book running manager for the offering.

ShowHide Related Items >><<
ARE Alexandria Real Estate
$164.78 /

-0.08 (-0.05%)

ARE Alexandria Real Estate
$164.78 /

-0.08 (-0.05%)

06/08/20 JMP Securities
Alexandria Real Estate resumed with an Outperform at JMP Securities
02/04/20 Mizuho
Alexandria Real Estate assumed with a Buy at Mizuho
12/18/19 JPMorgan
JPMorgan makes 17 REIT rating changes in conjunction with 2020 outlook
12/18/19 RBC Capital
Alexandria Real Estate downgraded to Outperform from Top Pick at RBC Capital
ARE Alexandria Real Estate
$164.78 /

-0.08 (-0.05%)

  • 07
    Jul
  • 07
    Jan
ARE Alexandria Real Estate
$164.78 /

-0.08 (-0.05%)

Syndicate
Alexandria Real Estate announces offering of 5M shares of common stock » 16:12
07/06/20
07/06
16:12
07/06/20
16:12
ARE

Alexandria Real Estate

$164.74 /

-0.12 (-0.07%)

Alexandria Real Estate…

Alexandria Real Estate Equities announced that it is commencing an underwritten public offering of 5M shares of the company's common stock, subject to market conditions, in connection with the forward sale agreements. Citigroup, BofA Securities, Goldman Sachs, and J.P. Morgan are acting as joint book-running managers for the offering.

ShowHide Related Items >><<
ARE Alexandria Real Estate
$164.74 /

-0.12 (-0.07%)

ARE Alexandria Real Estate
$164.74 /

-0.12 (-0.07%)

06/08/20 JMP Securities
Alexandria Real Estate resumed with an Outperform at JMP Securities
02/04/20 Mizuho
Alexandria Real Estate assumed with a Buy at Mizuho
12/18/19 JPMorgan
JPMorgan makes 17 REIT rating changes in conjunction with 2020 outlook
12/18/19 RBC Capital
Alexandria Real Estate downgraded to Outperform from Top Pick at RBC Capital
ARE Alexandria Real Estate
$164.74 /

-0.12 (-0.07%)

  • 07
    Jan
ARE Alexandria Real Estate
$164.74 /

-0.12 (-0.07%)

Over a month ago
Initiation
Alexandria Real Estate resumed with an Outperform at JMP Securities » 06:29
06/08/20
06/08
06:29
06/08/20
06:29
ARE

Alexandria Real Estate

$158.66 /

+7.54 (+4.99%)

JMP Securities analyst…

JMP Securities analyst Aaron Hecht resumed coverage of Alexandria Real Estate with an Outperform rating and $185 price target. The company's underlying real estate assets are ideally positioned to outperform during/following the COVID-19 pandemic, as a number of its tenants working directly on COVID-19 therapeutics, the analyst tells investors in a research note. Hecht adds that the value of the biotech industry has been spotlighted during the pandemic.

ShowHide Related Items >><<
ARE Alexandria Real Estate
$158.66 /

+7.54 (+4.99%)

ARE Alexandria Real Estate
$158.66 /

+7.54 (+4.99%)

02/04/20 Mizuho
Alexandria Real Estate assumed with a Buy at Mizuho
12/18/19 JPMorgan
JPMorgan makes 17 REIT rating changes in conjunction with 2020 outlook
12/18/19 RBC Capital
Alexandria Real Estate downgraded to Outperform from Top Pick at RBC Capital
12/18/19 JPMorgan
Alexandria Real Estate upgraded to Overweight from Neutral at JPMorgan
ARE Alexandria Real Estate
$158.66 /

+7.54 (+4.99%)

ARE Alexandria Real Estate
$158.66 /

+7.54 (+4.99%)

Earnings
Fly Intel: Top five weekend stock stories » 18:47
05/10/20
05/10
18:47
05/10/20
18:47
TSLA

Tesla

$819.01 /

+38.8 (+4.97%)

, GILD

Gilead

$77.45 /

-0.14 (-0.18%)

, RF

Regions Financial

$10.32 /

+0.465 (+4.72%)

, SNV

Synovus

$19.77 /

+1.11 (+5.95%)

, FFWM

First Foundation

$12.97 /

+0.28 (+2.21%)

, ACBI

Atlantic Capital

$11.68 /

+0.59 (+5.32%)

, TCF

TCF Financial

$28.19 /

+1.97 (+7.51%)

, CFG

Citizens Financial

$22.18 /

+0.935 (+4.40%)

, PB

Prosperity Bancshares

$60.04 /

+3.07 (+5.39%)

, BXS

BancorpSouth

$20.79 /

+1.2 (+6.13%)

, TD

Toronto-Dominion

$40.96 /

+0.79 (+1.97%)

, BMO

Bank of Montreal

$49.00 /

+1.06 (+2.21%)

, IBTX

Independent Bank

$30.41 /

+2.66 (+9.59%)

, PFE

Pfizer

$37.20 /

+0.24 (+0.65%)

, CTLT

Catalent

$71.91 /

+0.87 (+1.22%)

, LZAGY

Lonza

$0.00 /

+ (+0.00%)

, TMO

Thermo Fisher

$331.58 /

-7.1 (-2.10%)

, BYD

Boyd Gaming

$17.96 /

+0.75 (+4.36%)

, TCEHY

Tencent

$0.00 /

+ (+0.00%)

, BABA

Alibaba

$201.27 /

+4.85 (+2.47%)

, JD

JD.com

$46.79 /

+2.03 (+4.54%)

, EQIX

Equinix

$677.86 /

+3.05 (+0.45%)

, QTS

QTS Realty Trust

$65.29 /

+1.315 (+2.06%)

, AMT

American Tower

$238.18 /

+2.92 (+1.24%)

, SBAC

SBA Communications

$291.43 /

+5.44 (+1.90%)

, ARE

Alexandria Real Estate

$151.68 /

+0.195 (+0.13%)

, PLD

Prologis

$89.95 /

+1.94 (+2.20%)

, DEI

Douglas Emmett

$29.48 /

+1.02 (+3.58%)

, AVB

AvalonBay

$163.83 /

+3.62 (+2.26%)

, EQR

Equity Residential

$64.13 /

+1.07 (+1.70%)

, ADC

Agree Realty

$64.76 /

+1.2 (+1.89%)

, FCPT

Four Corners Property Trust

$21.86 /

+0.69 (+3.26%)

Catch up on the…

Catch up on the weekend's top five stories with this list compiled by The Fly: 1. In a blog post, Tesla (TSLA) said that, "Contrary to the Governor's recent guidance and support from the City of Fremont, Alameda County is insisting we should not resume operations. This is not for lack of trying or transparency since we have met with and collaborated on our restart plans with the Alameda County Health Care Services Agency. Unfortunately, the County Public Health Officer who is making these decisions has not returned our calls or emails. [...] the County's position left us no choice but to take legal action to ensure that Tesla and its employees can get back to work. We filed a lawsuit on May 9 asking the court to invalidate the County Orders, to the extent the County claims they prevent Tesla from resuming operations. Meanwhile, CEO Elon Mush said in a series of tweets that, "Tesla is filing a lawsuit against Alameda County immediately. The unelected & ignorant "Interim Health Officer" of Alameda is acting contrary to the Governor, the President, our Constitutional freedoms & just plain common sense! [...] Frankly, this is the final straw. Tesla will now move its HQ and future programs to Texas/Nevada immediately. If we even retain Fremont manufacturing activity at all, it will be dependent on how Tesla is treated in the future. Tesla is the last carmaker left in CA." 2. The U.S. Department of Health and Human Services said it would allow state health departments to distribute Gilead Sciences' (GILD) remdesivir drug to fight COVID-19, and the U.S. would receive about 40% of the drug maker's global donation, according to Reuters. 3. The U.S. has lost nearly 40% of its banks since the financial crisis, largely due to industry consolidation, and many industry observers see the trend resuming once the nation's health crisis passes and economic activity begins to normalize, Carleton English wrote in this week's edition of Barron's. The publication identified at least six potential targets, namely Regions Financial (RF), Synovus Financial (SNV), First Foundation (FFWM), Atlantic Capital (ACBI), TCF Financial (TCF), and Citizens Financial (CFG). On the potential buyers side, Barron's highlights Prosperity Bancshares (PB), BancorpSouth Bank (BXS), Toronto-Dominion Bank (TD), Bank of Montreal (BMO), and Independent Bank (IBTX). 4. Pfizer (PFE) said it is in talks to shift more of its medicine production to outside contractors as it prepares for large-scale production of an experimental vaccine to prevent COVID-19, should it prove safe and effective, Reuters' Carl O'Donnell and Michael Erman reported. The U.S. drugmaker is tapping its network of around 200 outside contractors, which includes Catalent (CTLT), Lonza Group (LZAGY), and Thermo Fisher Scientific (TMO), to play a bigger role in producing some of its existing medicines, Mike McDermott, president of global supply at Pfizer, told Reuters in an interview. 5. Boyd Gaming (BYD), Tencent (TCEHY), Alibaba (BABA), JD.com (JD), Equinix (EQIX), QTS Realty (QTS), American Tower (AMT), SBA Communications (SBAC), Alexandra Real Estate (ARE), Prologis (PLD), Douglas Emmett (DEI), AvalonBay Communities (AVB), Equity Residential (EQR), Agree Realty (ADC), and Four Corners (FCPT) saw positive mentions in this week's edition of Barron's.

ShowHide Related Items >><<
TSLA Tesla
$819.01 /

+38.8 (+4.97%)

05/07/20 Roth Capital
Tesla's reported suspension in Shanghai adds downside risk, says Roth Capital
05/04/20 Morgan Stanley
Tesla price target raised to $680 from $440 at Morgan Stanley
05/01/20 Morgan Stanley
Musk tweet reflects 'genuine concern' over Q2 declines, says Morgan Stanley
05/01/20 Deutsche Bank
Tesla price target raised to $850 from $510 at Deutsche Bank
GILD Gilead
$77.45 /

-0.14 (-0.18%)

05/06/20 Goldman Sachs
Goldman says Novo Nordisk NASH data a 'clear positive' for Intercept
05/05/20 Citi
ICER value of Remdesivir at $4,500 supportive of value, says Citi
05/04/20 Benchmark
Regeneron report more about COVID-19 progress than earnings, says Benchmark
05/04/20 Piper Sandler
Remdesivir given 'fairly lax' treatment requirements, say Piper Sandler
RF Regions Financial
$10.32 /

+0.465 (+4.72%)

04/14/20 Compass Point
Regions Financial initiated with a Neutral at Compass Point
03/19/20 Goldman Sachs
Regions Financial upgraded to Conviction Buy from Buy at Goldman Sachs
03/17/20 Wedbush
Regions Financial added to Best List Ideas at Wedbush
03/09/20 Raymond James
Regions Financial double downgraded at Raymond James as oil prices sink
SNV Synovus
$19.77 /

+1.11 (+5.95%)

03/30/20 Wells Fargo
Synovus upgraded to Overweight from Equal Weight at Wells Fargo
03/30/20 Wells Fargo
Synovus upgraded to Overweight from Equal Weight at Wells Fargo
03/06/20 Truist
SunTrust cuts price targets on Banks amid lower interest rate environment
03/04/20 DA Davidson
Synovus price target lowered to $35 from $42 at DA Davidson
FFWM First Foundation
$12.97 /

+0.28 (+2.21%)

04/24/20 Piper Sandler
First Foundation upgraded to Overweight from Neutral at Piper Sandler
03/24/20
Fly Intel: Top five analyst initiations
03/23/20 Wedbush
Wedbush starts First Foundation at Outperform, cites defensive positioning
03/23/20 Wedbush
First Foundation initiated with an Outperform at Wedbush
ACBI Atlantic Capital
$11.68 /

+0.59 (+5.32%)

09/05/19 Keefe Bruyette
Atlantic Capital downgraded to Market Perform from Outperform at Keefe Bruyette
TCF TCF Financial
$28.19 /

+1.97 (+7.51%)

04/17/20 Wedbush
TCF Financial upgraded to Outperform from Neutral at Wedbush
04/17/20 Wedbush
TCF Financial upgraded to Outperform from Neutral at Wedbush
03/10/20
Fly Intel: Top five analyst upgrades
03/10/20 UBS
TCF Financial upgraded to Buy from Neutral at UBS
CFG Citizens Financial
$22.18 /

+0.935 (+4.40%)

05/04/20 UBS
Wells Fargo, PNC Financial cut to Sell, Keycorp cut to Neutral at UBS
05/04/20 UBS
Citizens Financial upgraded to Buy from Neutral at UBS
04/20/20 Morgan Stanley
Amazon removed from Fresh Money Buy List at Morgan Stanley
04/14/20 Compass Point
Citizens Financial initiated with a Neutral at Compass Point
PB Prosperity Bancshares
$60.04 /

+3.07 (+5.39%)

04/30/20 Truist
Prosperity Bancshares price target raised to $75 from $55 at SunTrust
04/30/20 BofA
Prosperity Bancshares upgraded to Neutral from Underperform at BofA
04/30/20 BofA
Prosperity Bancshares upgraded to Neutral from Underperform at BofA
04/14/20 Compass Point
Prosperity Bancshares initiated with a Buy at Compass Point
BXS BancorpSouth
$20.79 /

+1.2 (+6.13%)

03/02/20 Janney Montgomery Scott
BancorpSouth upgraded to Buy from Neutral at Janney Montgomery Scott
01/30/20 DA Davidson
BancorpSouth upgraded to Buy from Neutral at DA Davidson
09/25/19
Fly Intel: Top analyst upgrades
TD Toronto-Dominion
$40.96 /

+0.79 (+1.97%)

03/13/20 BofA
Toronto-Dominion downgraded to Neutral from Buy at BofA
03/09/20 Barclays
Toronto-Dominion price target lowered to C$69 from C$78 at Barclays
02/28/20 Canaccord
Toronto-Dominion downgraded to Hold from Buy at Canaccord
02/04/20
Fly Intel: Top five analyst upgrades
BMO Bank of Montreal
$49.00 /

+1.06 (+2.21%)

04/28/20 TD Securities
Bank of Montreal downgraded to Buy on outperformance at TD Securities
04/28/20 TD Securities
Bank of Montreal downgraded to Buy from Action List Buy at TD Securities
03/20/20 TD Securities
Bank of Montreal upgraded to Buy from Hold at TD Securities
03/09/20 Barclays
Bank of Montreal price target lowered to C$85 from C$105 at Barclays
IBTX Independent Bank
$30.41 /

+2.66 (+9.59%)

02/20/20 UBS
Texas Capital upgraded to Neutral from Sell at UBS
01/29/20 Stephens
Stephens ups Independent Bank to Overweight, says integration risk priced in
01/29/20 Stephens
Independent Bank upgraded to Overweight from Equal Weight at Stephens
12/18/19 Stephens
Independent Bank downgraded to Equal Weight from Overweight at Stephens
PFE Pfizer
$37.20 /

+0.24 (+0.65%)

05/10/20 Piper Sandler
Piper Sandler bullish on Eidos, says AG10 opportunity remains very exciting
04/29/20 Piper Sandler
Piper backs Overweight on Opko as BioReference starts COVID-19 antibody testing
04/28/20 SVB Leerink
SVB Leerink bullish on Zentalis, initiates with an Outperform
04/28/20 BofA
BioNTech downgraded to Neutral from Buy at BofA
CTLT Catalent
$71.91 /

+0.87 (+1.22%)

05/06/20 Baird
Catalent price target raised to $74 from $63 at Baird
04/29/20 Stephens
Catalent deal with J&J could represent $600M revenue opportunity, says Stephens
04/20/20 RBC Capital
Catalent initiated with an Outperform at RBC Capital
03/11/20 JPMorgan
JPMorgan continues to recommend select exposure to Life Science Tools
LZAGY Lonza
$0.00 /

+ (+0.00%)

TMO Thermo Fisher
$331.58 /

-7.1 (-2.10%)

04/23/20 SVB Leerink
Thermo Fisher price target raised to $365 from $330 at SVB Leerink
04/23/20 Needham
Thermo Fisher price target raised to $383 from $341 at Needham
04/21/20 Wells Fargo
Danaher price target raised to $170 from $155 at Wells Fargo
03/30/20 Wells Fargo
Thermo Fisher price target lowered to $300 from $345 at Wells Fargo
BYD Boyd Gaming
$17.96 /

+0.75 (+4.36%)

04/29/20 Deutsche Bank
Boyd Gaming price target lowered to $22 from $42 at Deutsche Bank
04/29/20 Union Gaming
Boyd Gaming downgraded to Hold from Buy at Union Gaming
04/27/20 Nomura Instinet
Nomura sees 'attractive upside' in Boyd and Penn National as casinos reopen
04/27/20 Nomura Instinet
Boyd, Penn offer 'attractive upside' upon reopening, says Nomura Instinet
TCEHY Tencent
$0.00 /

+ (+0.00%)

03/23/20 Oppenheimer
Tencent, Baidu, Alibaba attractive at current levels, says Oppenheimer
03/20/20 China Renaissance
Huya upgraded to Buy on valuation at China Renaissance
02/25/20 Goldman Sachs
Huya downgraded to Neutral on cost inflation at Goldman Sachs
02/10/20 Oppenheimer
Tencent,Tencent Music more resilient amid coronavirus outbreak, says Oppenheimer
BABA Alibaba
$201.27 /

+4.85 (+2.47%)

04/09/20 Morgan Stanley
Alibaba 'core of core' revenue recovery outlook improved, says Morgan Stanley
02/20/20 Argus
Alibaba price target raised to $260 from $210 at Argus
JD JD.com
$46.79 /

+2.03 (+4.54%)

04/14/20 Morgan Stanley
JD.com upgraded to Overweight from Equal Weight at Morgan Stanley
03/17/20 Bernstein
JD.com upgraded to Outperform from Market Perform at Bernstein
03/03/20 Susquehanna
JD.com price target raised to $45 from $35 at Susquehanna
03/03/20 Benchmark
JD.com price target raised to $60 from $42 at Benchmark
EQIX Equinix
$677.86 /

+3.05 (+0.45%)

05/07/20 Wells Fargo
Equinix price target raised to $745 from $675 at Wells Fargo
05/07/20 JPMorgan
Equinix price target raised to $725 from $675 at JPMorgan
04/27/20 JPMorgan
JPMorgan positive on data center demand, Equinix top large cap pick
04/16/20 Raymond James
Equinix double downgraded to Market Perform at Raymond James on valuation
QTS QTS Realty Trust
$65.29 /

+1.315 (+2.06%)

05/04/20
Fly Intel: Top five analyst upgrades
05/04/20 Jefferies
QTS Realty Trust, CyrusOne upgraded to Buy on WFH boost at Jefferies
05/04/20 Jefferies
QTS Realty Trust upgraded to Buy from Hold at Jefferies
04/30/20 JPMorgan
QTS Realty Trust target raised to $70 on 'solid' Q1 at JPMorgan
AMT American Tower
$238.18 /

+2.92 (+1.24%)

05/06/20 Wells Fargo
American Tower price target raised to $272 from $265 at Wells Fargo
04/30/20 Credit Suisse
American Tower price target lowered to $300 from $308 at Credit Suisse
04/28/20 Credit Suisse
American Tower initiated with an Outperform at Credit Suisse
04/23/20 Oppenheimer
Facebook stake in Reliance Jio positive for American Tower, says Oppenheimer
SBAC SBA Communications
$291.43 /

+5.44 (+1.90%)

05/06/20 Wells Fargo
SBA Communications price target raised to $325 from $305 at Wells Fargo
04/28/20 Credit Suisse
SBA Communications initiated with an Outperform at Credit Suisse
04/07/20 Wells Fargo
SBA Communications upgraded to Overweight at Wells Fargo
04/07/20 MoffettNathanson
SBA Communications upgraded to Buy from Neutral at MoffettNathanson
ARE Alexandria Real Estate
$151.68 /

+0.195 (+0.13%)

02/04/20 Mizuho
Alexandria Real Estate assumed with a Buy at Mizuho
12/18/19 JPMorgan
JPMorgan makes 17 REIT rating changes in conjunction with 2020 outlook
12/18/19 RBC Capital
Alexandria Real Estate downgraded to Outperform from Top Pick at RBC Capital
12/18/19 JPMorgan
Alexandria Real Estate upgraded to Overweight from Neutral at JPMorgan
PLD Prologis
$89.95 /

+1.94 (+2.20%)

04/24/20 Deutsche Bank
Prologis price target lowered to $90 from $96 at Deutsche Bank
04/13/20 Morgan Stanley
Morgan Stanley recommends Overweight Prologis, Underweight UPS pair trade
04/06/20 Stifel
Prologis price target raised to $85 from $76 at Stifel
03/18/20 Deutsche Bank
Deutsche Bank upgrades Simon Property to Buy amid COVID-19 risks
DEI Douglas Emmett
$29.48 /

+1.02 (+3.58%)

04/16/20 Jefferies
Douglas Emmett initiated with a Buy at Jefferies
03/26/20 RBC Capital
Cheesecake, AMC news highlight tenants financial stress, says RBC Capital
03/25/20 Evercore ISI
Douglas Emmett upgraded to Outperform from In Line at Evercore ISI
02/04/20 Mizuho
Douglas Emmett assumed with a Neutral at Mizuho
AVB AvalonBay
$163.83 /

+3.62 (+2.26%)

04/02/20 Mizuho
AvalonBay downgraded to Neutral from Buy at Mizuho
03/26/20 Piper Sandler
AvalonBay downgraded to Underweight from Neutral at Piper Sandler
03/10/20 BTIG
Investors Real Estate, AvalonBay price targets lowered at BTIG
02/18/20 Truist
AvalonBay price target raised to $235 from $222 at SunTrust
EQR Equity Residential
$64.13 /

+1.07 (+1.70%)

04/24/20 Piper Sandler
Equity Residential downgraded to Underweight from Neutral at Piper Sandler
03/17/20 Baird
Equity Residential upgraded to Neutral from Underperform at Baird
03/10/20 BTIG
Equity Residential upgraded to Buy from Neutral at BTIG
03/10/20 BTIG
Equity Residential upgraded to Buy from Neutral at BTIG
ADC Agree Realty
$64.76 /

+1.2 (+1.89%)

04/08/20 Odeon Capital
Agree Realty initiated with a Buy at Odeon Capital
04/07/20 Citi
Agree Realty price target lowered to $70 from $82 at Citi
12/12/19 Citi
Agree Realty upgraded to Buy from Neutral at Citi
12/05/19 Capital One
Agree Realty initiated with an Overweight at Capital One
FCPT Four Corners Property Trust
$21.86 /

+0.69 (+3.26%)

02/13/20 Ladenburg
Four Corners Property Trust could reveal catalysts on call, says Ladenburg
01/24/20
Fly Intel: Top five analyst initiations
01/24/20 Evercore ISI
Four Corners Property Trust initiated with an Outperform at Evercore ISI
12/18/19 JPMorgan
Four Corners Property Trust initiated with a Neutral at JPMorgan

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.